Northwest Clinical Research Center

Improving Lives Through Research

Contact Us

425.453.0404

US FDA Approved Trials For Clinical Depression

Northwest Clinical Research Center offers a variety of depression studies evaluating potential medication that has been approved for investigation by the US FDA (Food and Drug Administration).

If you are interested in participating in a clinical research study, you can schedule a no cost, in-person evaluation to meet with our doctors and see if our studies are the right fit for you.

To participate in a clinical trial, please give us a call to schedule at 425-453-0404.

For specific details of our ongoing trials, please see the links below, provided by the National Library of Medicine:

 

Depression

GZMH: A Phase 3, Multicenter, Randomized, Double-Blind, Parallel-Arm Study to Investigate the Efficacy and Safety of Adjunctive Treatment with Brenipatide in Delaying Time to Relapse Compared with Placebo in Adult Participants with Major Depressive Disorder (RENEWMDD-1) (ENROLLING)

NCT07412756

TRIAL DETAILS

GZMI: A Phase 3, Multicenter, Randomized, Double-Blind, Parallel-Arm Study to Investigate the Efficacy and Safety of Adjunctive Treatment with Brenipatide in Delaying Time to Relapse Compared with Placebo in Adult Participants with Major Depressive Disorder (RENEWMDD-2) (ENROLLING)

NCT07775300

TRIAL DETAILS

M25-987: A Phase 2, Multicenter, 6-Week, Double Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Icalcaprant in Subjects with Major Depressive Disorder (ENROLLING)

NCT07276997

TRIAL DETAILS

DT-101/201: A Phase 2 Double-blind, Randomised, Placebo-controlled Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of DT-101 in Adults with Major Depressive Disorder (ENROLLING)
NCT07300969

TRIAL DETAILS

DT-101/202: A Phase 2 Double-blind, Randomised, Placebo-controlled Trial to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of DT-101 in Adults with Major Depressive Disorder Receiving Pharmacological Therapy for Depression (ENROLLING)

NCT07610473

TRIAL DETAILS

ITI-007-505: A Randomized, Double-Blind, Placebo-controlled Multicenter Study to Assess the Efficacy and Safety of Lumateperone as Adjunctive Therapy in the Treatment of Patients with Major Depressive Disorder (ENROLLING)

NCT05850689

TRIAL DETAILS

42847922MDD3011: A Multicenter, Double-blind, Randomized, Placebo-controlled Study to Evaluate Efficacy and Safety of Seltorexant as Monotherapy in Adult and Elderly Participants With Major Depressive Disorder (MDD) and an Open-label Long-term Extension Treatment with Seltorexant (ENROLLING)

NCT07573176

TRIAL DETAILS

54135419TRD3015: A Randomized, Double-blind, Multicenter, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Esketamine Nasal Spray, Administered as Monotherapy, in Adult Participants With Treatment-resistant Depression (ENROLLING)

NCT07716098

TRIAL DETAILS

VP-VHX-896-3201: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED MULTICENTER STUDY TO ASSESS THE EFFICACY AND SAFETY OF MILSAPERIDONE AS ADJUNCTIVE THERAPY IN THE TREATMENT OF PATIENTS WITH MAJOR DEPRESSIVE DISORDER
NCT06830044

TRIAL DETAILS

Study Evaluation Process

  • Screening: Determine eligibility and safety through medical examinations, questionnaires, and interviews.
  • Informed Consent: Receive detailed information about the trial, including risks and benefits.
  • Treatment: Receive investigational medication and placebo, and follow the trail protocol regarding current treatments and medications.
  • Monitoring: Close monitoring of conditions and side effects through check-ups, laboratory tests, EKG’s and assessments.

NWCRC in Bellevue, WA. Research and medical studies patient lounge.

CONTACT US

To be contacted about this study, fill out the contact form or call 425-453-0404.

This field is for validation purposes and should be left unchanged.
We complete all visits in person. Do you live within 50 miles of Bellevue, WA?(Required)


Are you interested in participating in clinical trials?(Required)


Please indicated which study you are interested in.(Required)